| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ... Autophagy 12 (1), 1-222, 2016 | 11046* | 2016 |
| Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ... Autophagy 4 (2), 151-175, 2008 | 2702 | 2008 |
| Selection methods for high-producing mammalian cell lines SM Browne, M Al-Rubeai Trends in biotechnology 25 (9), 425-432, 2007 | 300 | 2007 |
| Cell death in bioreactors: a role for apoptosis RP Singh, M Al.‐Rubeai, CD Gregory, AN Emery Biotechnology and Bioengineering 44 (6), 720-726, 1994 | 278 | 1994 |
| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ... Autophagy 8 (12), 445-544, 2016 | 210* | 2016 |
| Apoptosis in cell culture M Al-Rubeai, RP Singh Current opinion in Biotechnology 9 (2), 152-156, 1998 | 206 | 1998 |
| Death mechanisms of animal cells in conditions of intensive agitation M Al‐Rubeai, RP Singh, MH Goldman, AN Emery Biotechnology and bioengineering 45 (6), 463-472, 1995 | 194 | 1995 |
| Retroviral vectors for human gene delivery S McTaggart, M Al-Rubeai Biotechnology advances 20 (1), 1-31, 2002 | 191 | 2002 |
| Cell death (apoptosis) in cell culture systems TG Cotter, M Al-Rubeai Trends in biotechnology 13 (4), 150-155, 1995 | 189 | 1995 |
| Introduction to viral vectors JN Warnock, C Daigre, M Al-Rubeai Viral vectors for gene therapy: methods and protocols, 1-25, 2011 | 180 | 2011 |
| Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1‐arrested CHO cells JX Bi, J Shuttleworth, M Al‐Rubeai Biotechnology and bioengineering 85 (7), 741-749, 2004 | 175 | 2004 |
| Influence of bcl‐2 on cell death during the cultivation of a Chinese hamster ovary cell line expressing a chimeric antibody BT Tey, RP Singh, L Piredda, M Piacentini, M Al‐Rubeai Biotechnology and bioengineering 68 (1), 31-43, 2000 | 174 | 2000 |
| Cell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies B Krampe, M Al-Rubeai Cytotechnology 62, 175-188, 2010 | 170 | 2010 |
| Prevention of hybridoma cell death by bcl‐2 during suboptimal culture conditions NH Simpson, AE Milner, M Al‐Rubeai Biotechnology and Bioengineering 54 (1), 1-16, 1997 | 169 | 1997 |
| The effects of agitation intensity with and without continuous sparging on the growth and antibody production of hybridoma cells SKW Oh, AW Nienow, M Al-Rubeai, AN Emery Journal of biotechnology 12 (1), 45-61, 1989 | 169 | 1989 |
| In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl‐2 gene NH Simpson, RP Singh, A Perani, C Goldenzon, M Al‐Rubeai Biotechnology and Bioengineering 59 (1), 90-98, 1998 | 165 | 1998 |
| Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures M Al-Rubeai, AN Emery Journal of biotechnology 16 (1-2), 67-85, 1990 | 163 | 1990 |
| Bioreactor systems for the production of biopharmaceuticals from animal cells JN Warnock, M Al‐Rubeai Biotechnology and applied biochemistry 45 (1), 1-12, 2006 | 160 | 2006 |
| Estimation of disruption of animal cells by laminar shear stress C Born, Z Zhang, M Al‐Rubeai, CR Thomas Biotechnology and bioengineering 40 (9), 1004-1010, 1992 | 158 | 1992 |
| Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures M Al-Rubeai, AN Emery, S Chalder, DC Jan Cytotechnology 9, 85-97, 1992 | 151 | 1992 |
